1. Novel CAC Dispersion and Density Score to Predict Myocardial Infarction and Cardiovascular Mortality.
作者: Gavin Huangfu.;Abdul R Ihdayhid.;Simon Kwok.;John Konstantopoulos.;Kai Niu.;Juan Lu.;Harry Smallbone.;Gemma A Figtree.;Clara K Chow.;Lawrence Dembo.;Brendan Adler.;Christian Hamilton-Craig.;Stuart M Grieve.;Matthew T V Chan.;Craig Butler.;Vikas Tandon.;Peter Nagele.;Pamela K Woodard.;Marko Mrkobrada.;Wojciech Szczeklik.;Yang Faridah Abdul Aziz.;Bruce Biccard.;Philip James Devereaux.;Tej Sheth.;Girish Dwivedi.;Benjamin J W Chow.
来源: Circ Cardiovasc Imaging. 2025年e018059页
Coronary artery calcification (CAC) provides robust prediction for major adverse cardiovascular events (MACE), but current techniques disregard plaque distribution and protective effects of high CAC density. We investigated whether a novel CAC-dispersion and density (CAC-DAD) score will exhibit superior prognostic value compared with the Agatston score (AS) for MACE prediction.
2. Mid-Term Reassessment of Waitlist and Posttransplant Outcomes Under the 2018 Heart Allocation System: Improved All-Cause Survival.
作者: Yeahwa Hong.;Nidhi Iyanna.;Ander Dorken-Gallastegi.;Umar Nasim.;Edward T Horn.;Michael A Mathier.;Dennis M McNamara.;Gavin W Hickey.;Mary E Keebler.;David J Kaczorowski.
来源: Circ Heart Fail. 2025年e012663页
This study evaluates clinical trends and mid-term waitlist and posttransplant outcomes following the 2018 heart allocation policy change.
3. Endothelin-1 and Accelerated Cardiac Allograft Vasculopathy After Heart Transplantation.
作者: Rushi V Parikh.;Alexandra Klomhaus.;Juka S Kim.;Abdul Assi.;David Tehrani.;Danielle Campbell.;Lisa Bang.;Rubine Fleming.;Kan Saito.;Takeshi Nishi.;Yasuhiro Honda.;Kiran K Khush.;William F Fearon.;Ali Nsair.;Gregg C Fonarow.
来源: Circ Heart Fail. 2025年e013288页 4. Guideline-Directed Medical Therapy Use in the STRONG-HF Trial.
作者: Xiang Zhang.;Beth Davison.;Marianna Adamo.;Mattia Arrigo.;Jan Biegus.;Ovidiu Chioncel.;Alain Cohen-Solal.;Gad Cotter.;Christopher Edwards.;Antoine Kimmoun.;Carolyn S P Lam.;Alexandre Mebazaa.;Marco Metra.;Maria Novosadova.;Peter S Pang.;Karen Sliwa.;Koji Takagi.;Adriaan A Voors.;Justin A Ezekowitz.
来源: Circ Heart Fail. 2025年e012716页
Assessment of medication changes in heart failure trials and registries is complex and may not capture the entirety of care. A comprehensive and standardized method is needed. We used different methods to assess the use of guideline-directed medical therapies (GDMT) and verified the association between GDMT intensity score with the STRONG-HF trial (Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP Testing of Heart Failure Therapies) clinical outcomes.
5. Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD.
作者: Romit Bhattacharya.;Christopher S Marnell.;So Mi Jemma Cho.;Aniruddh Patel.;Yunfeng Ruan.;Satoshi Koyama.;Amanda Jowell.;Mark Trinder.;Sara Haidermota.;Kim Lannery.;Michael C Honigberg.;Seyedeh M Zekevat.;Ida Surakka.;Gina M Peloso.;Pradeep Natarajan.
来源: Circ Genom Precis Med. 2025年e004937页
Prior work suggests modifiable cardiovascular risk factors (CRFs) account for 80% to 90% of the risk for incident myocardial infarction. The contributions of genetic and other novel CRFs have not been simultaneously assessed in contemporary data sets.
6. Determinants of Right Heart Hemodynamic Derangement in Patients With and Without Tricuspid Regurgitation.
作者: Sergio Caravita.;Michele Liberatore.;Luigi P Badano.;Maria Felicia Gagliardi.;Leila De Lorenzo.;Antonio Sorropago.;Cosmo Godino.;Michele Tomaselli.;Ettore Lanzarone.;Giovanni Battista Perego.;Jean-Luc Vachiéry.;Marat Fudim.;Gianfranco Parati.;Denisa Muraru.;Claudia Baratto.
来源: Circ Heart Fail. 2025年e012813页
The determinants of tricuspid regurgitation (TR) hemodynamic severity remain to be established. We explored the hemodynamic correlates of right atrial (RA) pressure and stroke volume (SV) in patients with and without TR, and assessed the reliability of the indirect Fick method in relation to TR severity.
7. Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study.
作者: Carlo Fumagalli.;Mattia Zampieri.;Roberto Presta.;Greta Pini.;Giulia Vetere.;Alessia Argirò.;Simone Longhi.;Giacomo Tini.;Beatrice Musumeci.;Giuseppe Limongelli.;Giuseppe Palmiero.;Federica Verrillo.;Matteo Beltrami.;Mario Bo.;Gaetano De Ferrari.;Lorenzo Tofani.;Celestino Sardu.;Raffaele Marfella.;Niccolò Marchionni.;Federico Perfetto.;Iacopo Olivotto.;Stefano Fumagalli.;Mathew S Maurer.;Marianna Fontana.;Andrea Ungar.;Francesco Cappelli.
来源: Circ Heart Fail. 2025年e012777页
The prevalence of transthyretin cardiac amyloidosis among older adults (often octogenarians) is increasing. We aimed to determine whether age and geriatric syndromes bear any impact on the management and outcomes in transthyretin cardiac amyloidosis and assess the risk of ageism.
8. Hypokalemia During Decongestion With Loop Diuretics and Hydrochlorothiazide, a Post Hoc Analysis of the CLOROTIC Trial.
作者: Alicia Conde-Martel.;Marta Hernández-Meneses.;José Luís Morales-Rull.;Jesús Casado.;Margarita Carrera-Izquierdo.;Marta León.;Marta Sánchez-Marteles.;Melitón Francisco Dávila-Ramos.;Carolina Hernández-Carballo.;Pau Llácer.;Mari Carmen Moreno-García.;Prado Salamanca-Bautista.;Francesc Formiga.;Luís Manzano.;Joan Carles Trullàs.
来源: Circ Heart Fail. 2025年e012914页
In patients with acute heart failure, the addition of hydrochlorothiazide (HCTZ) to furosemide increased the diuretic response in the CLOROTIC trial (Combining Loop with Thiazide Diuretics for Decompensated Heart Failure). The aim of this subanalysis was to evaluate the incidence and risk factors for hypokalemia, and its impact on mortality and readmissions.
9. Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
作者: Yingchao Gong.;Xue Lu.;Xingchen Wang.;Yinfang Wang.;Zhida Shen.;Yun Gao.;Lenan Zhuang.;Luyang Yu.;Jiawen Chen.;Qinfeng Li.;Fuyu Qiu.;Jun Lin.;Yuhang Tao.;Chenyang Jiang.;Guosheng Fu.;Peng Zhang.;Dongwu Lai.
来源: Circulation. 2025年
Pathological cardiac remodeling after myocardial infarction (MI) is a leading cause of heart failure and sudden death. The detailed mechanisms underlying the transition to heart failure after MI are not fully understood. Disruptions in the endoplasmic reticulum (ER)-mitochondria connectivity, along with mitochondrial dysfunction, are substantial contributors to this remodeling process. In this study, we aimed to explore the impact of mitochondrial tumor suppressor 1A (Mtus1A) on cardiac remodeling subsequent to MI and elucidate its regulatory role in ER-mitochondria interactions.
10. Partnership Model of Regionalized Care for Congenital Heart Disease in Resource-Limited Settings: Results From the ASSIST Project.
作者: Guocheng Shi.;Shuyu Chen.;Jin Shentu.;Nian Liu.;Hongbo Luo.;Chunxiang Li.;Lin Chen.;Kai Luo.;Qiang Chen.;Qiliang Zhang.;Jianfeng Zhang.;Zhaohui Lu.;Qi Sun.;Hao Zhang.;Xike Wang.;Huiwen Chen.
来源: Circulation. 2025年
Equal access to care for patients with congenital heart disease (CHD) remains unrealized globally. The ASSIST project (Academic Medical Hospitals-Local Institutions collaboration) is an ongoing national quality initiative implemented in low-resource settings in China attempting to reduce gaps in access to CHD care. This study sought to evaluate its feasibility and effectiveness.
11. Exercise Intolerance and Response to Training in Patients With Postacute Sequelae of SARS-CoV2 (Long COVID): A Scientific Statement From the American Heart Association.
作者: William K Cornwell.;Benjamin D Levine.;Diane Baptiste.;Nicole Bhave.;Sarika Desai.;Elizabeth Dineen.;Matthew Durstenfeld.;Justin Edward.;Mu Huang.;Roni Jacobsen.;Jonathan H Kim.;Erica Spatz.; .
来源: Circulation. 2025年
The postacute sequelae of SARS-CoV-2, also known as Long COVID, may affect 10% to 25% of individuals diagnosed with SARS-CoV-2. More than 100 symptoms have been reported among patients with Long COVID, but almost all patients report severe fatigue, orthostatic intolerance, shortness of breath, and reductions in exercise tolerance. Emerging data suggest that cardiovascular deconditioning plays a major role in the development of this syndrome and that reductions in functional capacity among patients with Long COVID are comparable to reductions seen among individuals with cardiovascular deconditioning resulting from bed rest. Concern has been raised about the use of exercise training as part of the management strategy for patients with Long COVID. However, exercise training appropriately tailored to the patient with cardiovascular deconditioning may be an effective strategy to facilitate improvement in symptoms. This American Heart Association scientific statement provides a concise yet comprehensive overview of mechanisms contributing to development of Long COVID and methods by which exercise training may be applied to this unique patient population to alleviate symptoms and improve quality of life. In addition, methods of reintroducing exercise and return to play among athletes affected by COVID-19 are discussed.
12. New Algorithm for Estimating Left Ventricular Filling Pressure by Echocardiography.
作者: Hossam Lababidi.;Wissam Rahi.;Otto A Smiseth.;Kristen Billick.;Katsuji Inoue.;Faraz H Khan.;Øyvind S Andersen.;Eusebio García-Izquierdo.;Jong-Won Ha.;Nobuyuki Ohte.;Einar Gude.;Rajeev C Mohan.;J Thomas Heywood.;Allan Klein.;Sherif F Nagueh.
来源: Circulation. 2025年
Evaluation of whether dyspnea has a cardiac cause is essential. Guidelines from 2016 were reported to result in a high incidence of indeterminate left ventricular (LV) filling pressure. We sought to validate a new algorithm for the estimation of LV filling pressure (LVFP) in a multicenter study, with the objective of decreasing the yield of indeterminate filling pressure and increasing accuracy.
13. Cardiac CT Versus Transesophageal Echocardiography Following Left Atrial Appendage Closure: A Systemic Review and Meta-Analysis.
作者: Bryan E-Xin Tan.;Faiz Baqai.;Fernando Padilla.;Nadeem Nimri.;Jim W Cheung.;Anupama Kottam.;Hector M Medina.
来源: Circ Cardiovasc Imaging. 2025年e018151页
In the landmark WATCHMAN trials, transesophageal echocardiography (TEE) was used to evaluate peri-device leak (PDL) and device-related thrombus (DRT) after percutaneous left atrial appendage closure (LAAC). We aimed to investigate the diagnostic utility of cardiac computed tomography angiography (CCTA) compared with TEE for post-LAAC device surveillance.
14. Sex Differences in Utilization of Donation After Circulatory Death Donors for Heart Transplantation and Associated Outcomes.
作者: Ersilia M DeFilippis.;Maria Masotti.;Elena M Donald.;Joanna Eichler.;Bhavadharini Ramu.;Tessa Watt.;Michael S Mulvihill.;Koji Takeda.;Nir Uriel.;Rebecca Cogswell.
来源: Circ Heart Fail. 2025年e012835页
The use of donation after circulatory death (DCD) donors for heart transplantation (HT) is increasing in the United States. Whether sex differences exist in DCD HT utilization and outcomes is unknown.
16. Improving Clinical Utility of Fetal Cine CMR Using Deep Learning Super-Resolution.
作者: Thomas M Vollbrecht.;Christopher Hart.;Christoph Katemann.;Alexander Isaak.;Marilia B Voigt.;Claus C Pieper.;Daniel Kuetting.;Annegret Geipel.;Brigitte Strizek.;Julian A Luetkens.
来源: Circ Cardiovasc Imaging. 2025年e018090页
Fetal cardiovascular magnetic resonance is an emerging tool for prenatal congenital heart disease assessment, but long acquisition times and fetal movements limit its clinical use. This study evaluates the clinical utility of deep learning super-resolution reconstructions for rapidly acquired, low-resolution fetal cardiovascular magnetic resonance.
18. Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA.
作者: Rajan Rehan.;Chinmay Khandur.;Christopher C Y Wong.;James Weaver.;Pankaj Jain.;Mark Adams.;Martin K C Ng.;Jennifer A Tremmel.;Andy S C Yong.
来源: Circ Cardiovasc Interv. 2025年e015339页
Coronary artery spasm (CAS) is a common cause of angina with nonobstructive coronary arteries (ANOCA). While acetylcholine provocation testing is the diagnostic gold standard, protocol variations have led to discrepancies in diagnostic accuracy. This study aimed to compare the diagnostic validity of conventional versus high-dose acetylcholine regimens in patients with ANOCA.
19. Invasive Coronary Function Testing in Patients With Prior PCI Who Have Persistent ANOCA.
作者: Vedant S Pargaonkar.;Christopher C Y Wong.;Yasuhiro Honda.;Ingela Schnittger.;Jennifer A Tremmel.
来源: Circ Cardiovasc Interv. 2025年e015344页
Patients with postpercutaneous coronary intervention (PCI) angina are challenging to manage. Comprehensive coronary function testing (CFT) can identify occult coronary abnormalities in patients with angina and nonobstructive coronary arteries. Its utility in patients with post-PCI and persistent angina who have no obstructive coronary artery disease is unexplored.
20. Letter by Sacoransky Regarding Article, "Deep Learning-Derived Cardiac Chamber Volumes and Mass From PET/CT Attenuation Scans: Associations With Myocardial Flow Reserve and Heart Failure". |